AMC Score 250 Explained: Why It Is Not the Same as Scoring 50%
AMC results are reported on a 0-500 scale with a pass mark of 250. That figure is not a percentage, and treating it as one leads candidates to misread their own readiness.
Read Insightinsights on clinical AI, guideline access, and the future of medicine
See objective, head-to-head comparisons of iatroX against other clinical tools.

AMC results are reported on a 0-500 scale with a pass mark of 250. That figure is not a percentage, and treating it as one leads candidates to misread their own readiness.
Read Insight
From 2026 the AMC raised the underlying pass standard for the MCQ exam while keeping the 0-500 scale and pass mark of 250 unchanged. Here is what actually needs to change in prepar...
Read Insight
Medical AI companies are expanding from narrow, single-purpose tools into fuller vertically integrated systems. Neko's raise is the clearest evidence yet of how far that shift can ...
Read Insight
As preventive AI systems capture more measurements, the central challenge shifts from detection to interpretation, and Neko's own published outcome data shows exactly why that dist...
Read Insight
Neko's visible product is the scanner. Its more durable competitive advantage may be the proprietary, repeated multimodal dataset the scanner exists to generate.
Read Insight
OpenEvidence and Neko Health are not competitors, but their valuations show that medical AI is splitting into distinct layers, from clinical knowledge to data-generating healthcare...
Read Insight
Neko, Prenuvo, Function Health and Q Bio are all racing to build the AI-powered health check, but each has made a different bet on what data matters most.
Read Insight
Neko Health's $700 million Series C suggests the next wave of valuable medical AI may not be chat interfaces at all, but systems that generate, own and interpret their own clinical...
Read Insight
Heidi's reported Midlands framework is a sign that the NHS AI scribe market is moving from clinician-led pilots to regional infrastructure, and the next contest will not simply be ...
Read Insight
Class IIa certification is meaningful regulatory assurance. It is not proof that Heidi, Tandem or TORTUS produces the best note, and comparing certificates properly requires more t...
Read Insight
A regional AVT deployment is a rare chance to build robust UK evidence, provided success is measured across safety, adoption and patient experience, not just minutes saved.
Read Insight
A 15-trust NHS framework is not one deployment. It is at least fifteen, each with its own settings, EPR estate and clinical safety governance to work through.
Read Insight